» Articles » PMID: 30744493

Small G Protein Signalling Modulator 2 (SGSM2) is Involved in Oestrogen Receptor-positive Breast Cancer Metastasis Through Enhancement of Migratory Cell Adhesion Via Interaction with E-cadherin

Overview
Journal Cell Adh Migr
Specialty Cell Biology
Date 2019 Feb 13
PMID 30744493
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The function of small G protein signalling modulators (SGSM1/2/3) in cancer remains unknown. Our findings demonstrated that SGSM2 is a plasma membrane protein that strongly interacted with E-cadherin/β-catenin. SGSM2 downregulation enhanced the phosphorylation of focal adhesion kinase (FAK; Y576/577), decreased the expression of epithelial markers such as E-cadherin, β-catenin, and Paxillin, and increased the expression of Snail and Twist-1, which reduced cell adhesion and promoted cancer cell migration. Oestrogen and fibronectin treatment was found to promote the colocalization of SGSM2 at the leading edge with phospho-FAK (Y397). The BioGRID database showed that SGSM2 potentially interacts with cytoskeleton remodelling and cell-cell junction proteins. These evidences suggest that SGSM2 plays a role in modulating cell adhesion and cytoskeleton dynamics during cancer migration.

Citing Articles

Salivary proteomics profiling reveals potential biomarkers for chronic kidney disease: a pilot study.

Picolo B, Silva N, Martins M, Almeida-Souza H, de Sousa L, Polveiro R Front Med (Lausanne). 2025; 11:1302637.

PMID: 39895822 PMC: 11784343. DOI: 10.3389/fmed.2024.1302637.


Luminal epithelial cells integrate variable responses to aging into stereotypical changes that underlie breast cancer susceptibility.

Sayaman R, Miyano M, Carlson E, Senapati P, Zirbes A, Shalabi S Elife. 2024; 13.

PMID: 39545637 PMC: 11723586. DOI: 10.7554/eLife.95720.


[Conbercept reverses TGF-β-induced epithelial-mesenchymal transition in human lens epithelial cells by regulating the TGF-β/Smad signaling pathway].

Zhu M, Wang J Nan Fang Yi Ke Da Xue Xue Bao. 2024; 44(8):1459-1466.

PMID: 39276041 PMC: 11378053. DOI: 10.12122/j.issn.1673-4254.2024.08.04.


Meta-analysis of integrated ChIP-seq and transcriptome data revealed genomic regions affected by estrogen receptor alpha in breast cancer.

Piryaei Z, Salehi Z, Ebrahimie E, Ebrahimi M, Kavousi K BMC Med Genomics. 2023; 16(1):219.

PMID: 37715225 PMC: 10503144. DOI: 10.1186/s12920-023-01655-z.


SGSM2 inhibits thyroid cancer progression by activating RAP1 and enhancing competitive RAS inhibition.

Su X, Chen D, Zhu L, Jia H, Cai J, Li P Cell Death Dis. 2022; 13(3):218.

PMID: 35264562 PMC: 8907342. DOI: 10.1038/s41419-022-04598-y.


References
1.
Meng X, Jin Y, Yu Y, Bai J, Liu G, Zhu J . Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer. 2009; 101(2):327-34. PMC: 2720209. DOI: 10.1038/sj.bjc.6605154. View

2.
Kawauchi T . Regulation of cell adhesion and migration in cortical neurons: Not only Rho but also Rab family small GTPases. Small GTPases. 2011; 2(1):36-40. PMC: 3116611. DOI: 10.4161/sgtp.2.1.15001. View

3.
Cheng H, Hsieh M, Yang J, Lin C, Lue K, Lu K . Nobiletin inhibits human osteosarcoma cells metastasis by blocking ERK and JNK-mediated MMPs expression. Oncotarget. 2016; 7(23):35208-23. PMC: 5085222. DOI: 10.18632/oncotarget.9106. View

4.
Balzac F, Avolio M, Degani S, Kaverina I, Torti M, Silengo L . E-cadherin endocytosis regulates the activity of Rap1: a traffic light GTPase at the crossroads between cadherin and integrin function. J Cell Sci. 2005; 118(Pt 20):4765-83. DOI: 10.1242/jcs.02584. View

5.
Parikh R, Wang P, Beumer J, Chu E, Appleman L . The potential roles of hepatocyte growth factor (HGF)-MET pathway inhibitors in cancer treatment. Onco Targets Ther. 2014; 7:969-83. PMC: 4061161. DOI: 10.2147/OTT.S40241. View